 |
Previous Article | Next Article 
The Journal of Neuroscience, June 15, 1999, 19(12):5026-5033
Attenuation of Ischemia-Induced Cellular and Behavioral Deficits
by X Chromosome-Linked Inhibitor of Apoptosis Protein Overexpression in
the Rat Hippocampus
Daigen
Xu1, 2,
Yves
Bureau4,
Dan C.
McIntyre4,
Donald W.
Nicholson5,
Peter
Liston2, 3,
Yanxia
Zhu1, 2,
Wei Gin
Fong3,
Stephen J.
Crocker1,
Robert G.
Korneluk2, 3, and
George S.
Robertson1, 6
1 Department of Cellular and Molecular Medicine,
Faculty of Medicine, University of Ottawa, Ottawa, Ontario K1H 8M5,
Canada, 2 Apoptogen and 3 Genetics Research
Laboratory, Children's Hospital of Eastern Ontario, Ottawa, Ontario
K1H 8L1, Canada, 4 Department of Psychology, Carleton
University, Ottawa, Ontario K1S 5B6, Canada, and
5 Apoptosis Research Program, Department of Biochemistry
and Molecular Biology and 6 Department of Pharmacology,
Merck Frosst Centre for Therapeutic Research, Kirkland, Quebec H9H 3L1,
Canada
Transient forebrain ischemia produced by four-vessel occlusion
(4-VO) triggers the delayed death of CA1 neurons in the hippocampus, resulting in behavioral deficits of spatial learning performance. We
demonstrate that CA1 neuronal loss induced by 4-VO (12 min) is preceded
by a selective and marked elevation of catalytically active caspase-3
in these neurons, indicative of apoptosis. Virally mediated
overexpression of the anti-apoptotic gene X chromosome-linked inhibitor
of apoptosis protein (XIAP) prevented both the production of
catalytically active caspase-3 and degeneration of CA1 neurons after
transient forebrain ischemia. CA1 neurons protected in this manner
appeared to function normally, as assessed by immunohistochemical detection of the neuronal activity marker nerve growth factor inducible-A and by spatial learning performance in the Morris water maze. These findings indicate that caspase-3 activation is a key
event in ischemic neuronal death and that blockade of this event by
XIAP overexpression permits CA1 neurons to survive and operate properly
after an ischemic insult.
Key words:
XIAP; caspase-3; DNA fragmentation; water maze; apoptosis; NGFI-A
Copyright © 1999 Society for Neuroscience 0270-6474/99/19125026-08$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
J. A. Emamaullee and A.M. J. Shapiro
Interventional Strategies to Prevent {beta}-Cell Apoptosis in Islet Transplantation.
Diabetes,
July 1, 2006;
55(7):
1907 - 1914.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Plesner, P. Liston, R. Tan, R. G. Korneluk, and C. B. Verchere
The X-Linked Inhibitor of Apoptosis Protein Enhances Survival of Murine Islet Allografts
Diabetes,
September 1, 2005;
54(9):
2533 - 2540.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Fischer and K. Schulze-Osthoff
New Approaches and Therapeutics Targeting Apoptosis in Disease
Pharmacol. Rev.,
June 1, 2005;
57(2):
187 - 215.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Cao, M. Xiao, F. Sun, X. Xiao, W. Pei, J. Li, S. H. Graham, R. P. Simon, and J. Chen
Cloning of a Novel Apaf-1-Interacting Protein: A Potent Suppressor of Apoptosis and Ischemic Neuronal Cell Death
J. Neurosci.,
July 7, 2004;
24(27):
6189 - 6201.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Perrelet, F. E. Perrin, P. Liston, R. G. Korneluk, A. MacKenzie, M. Ferrer-Alcon, and A. C. Kato
Motoneuron Resistance to Apoptotic Cell Death In Vivo Correlates with the Ratio between X-Linked Inhibitor of Apoptosis Proteins (XIAPs) and Its Inhibitor, XIAP-Associated Factor 1
J. Neurosci.,
April 14, 2004;
24(15):
3777 - 3785.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Conway, F. Zwerts, V. Van Eygen, A. DeVriese, N. Nagai, W. Luo, and D. Collen
Survivin-Dependent Angiogenesis in Ischemic Brain: Molecular Mechanisms of Hypoxia-Induced Up-Regulation
Am. J. Pathol.,
September 1, 2003;
163(3):
935 - 946.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Petrin, A. Baker, S. G. Coupland, P. Liston, M. Narang, K. Damji, B. Leonard, V. A. Chiodo, A. Timmers, W. Hauswirth, et al.
Structural and Functional Protection of Photoreceptors from MNU-Induced Retinal Degeneration by the X-Linked Inhibitor of Apoptosis
Invest. Ophthalmol. Vis. Sci.,
June 1, 2003;
44(6):
2757 - 2763.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Friedlander
Apoptosis and Caspases in Neurodegenerative Diseases
N. Engl. J. Med.,
April 3, 2003;
348(14):
1365 - 1375.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. W Scott, C. Sobotka-Briner, D. E. Wilkins, R. T. Jacobs, J. J. Folmer, W. J. Frazee, R. V. Bhat, S. V. Ghanekar, and D. Aharony
Novel Small Molecule Inhibitors of Caspase-3 Block Cellular and Biochemical Features of Apoptosis
J. Pharmacol. Exp. Ther.,
January 1, 2003;
304(1):
433 - 440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Guegan, M. Vila, G. Rosoklija, A. P. Hays, and S. Przedborski
Recruitment of the Mitochondrial-Dependent Apoptotic Pathway in Amyotrophic Lateral Sclerosis
J. Neurosci.,
September 1, 2001;
21(17):
6569 - 6576.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G.-M. Kim, J. Xu, J. Xu, S.-K. Song, P. Yan, G. Ku, X. M. Xu, and C. Y. Hsu
Tumor Necrosis Factor Receptor Deletion Reduces Nuclear Factor-{kappa}B Activation, Cellular Inhibitor of Apoptosis Protein 2 Expression, and Functional Recovery after Traumatic Spinal Cord Injury
J. Neurosci.,
September 1, 2001;
21(17):
6617 - 6625.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Cao, W. Pei, J. Lan, R. A. Stetler, Y. Luo, T. Nagayama, S. H. Graham, X.-M. Yin, R. P. Simon, and J. Chen
Caspase-Activated DNase/DNA Fragmentation Factor 40 Mediates Apoptotic DNA Fragmentation in Transient Cerebral Ischemia and in Neuronal Cultures
J. Neurosci.,
July 1, 2001;
21(13):
4678 - 4690.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Harlin, S. B. Reffey, C. S. Duckett, T. Lindsten, and C. B. Thompson
Characterization of XIAP-Deficient Mice
Mol. Cell. Biol.,
May 15, 2001;
21(10):
3604 - 3608.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. Vaudry, B. J. Gonzalez, M. Basille, T. F. Pamantung, M. Fontaine, A. Fournier, and H. Vaudry
The neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3/CPP32
PNAS,
November 21, 2000;
97(24):
13390 - 13395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. McLaughlin, B. Roozendaal, T. Dumas, A. Gupta, O. Ajilore, J. Hsieh, D. Ho, M. Lawrence, J. L. McGaugh, and R. Sapolsky
Sparing of neuronal function postseizure with gene therapy
PNAS,
October 26, 2000;
(2000)
210350097.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
W. W. Hauswirth and L. Beaufrere
Ocular Gene Therapy: Quo Vadis?
Invest. Ophthalmol. Vis. Sci.,
September 1, 2000;
41(10):
2821 - 2826.
[Full Text]
|
 |
|

|
 |

|
 |
 
C. R. Ozawa, J. J. Ho, D. J. Tsai, D. Y. Ho, and R. M. Sapolsky
Neuroprotective potential of a viral vector system induced by a neurological insult
PNAS,
July 19, 2000;
(2000)
160503997.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Holcik and R. G. Korneluk
Functional Characterization of the X-Linked Inhibitor of Apoptosis (XIAP) Internal Ribosome Entry Site Element: Role of La Autoantigen in XIAP Translation
Mol. Cell. Biol.,
July 1, 2000;
20(13):
4648 - 4657.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. R. Ozawa, J. J. Ho, D. J. Tsai, D. Y. Ho, and R. M. Sapolsky
Neuroprotective potential of a viral vector system induced by a neurological insult
PNAS,
August 1, 2000;
97(16):
9270 - 9275.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. McLaughlin, B. Roozendaal, T. Dumas, A. Gupta, O. Ajilore, J. Hsieh, D. Ho, M. Lawrence, J. L. McGaugh, and R. Sapolsky
Sparing of neuronal function postseizure with gene therapy
PNAS,
November 7, 2000;
97(23):
12804 - 12809.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|